HOLLIS EDEN PHARMACEUTICALS INC /DE/ 4

4 · HOLLIS EDEN PHARMACEUTICALS INC /DE/ · Filed Jan 22, 2008

Form 4

Period: 2008-01-17

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2008-01-17+25,000→ 25,000 total
Exercise: $1.62Exp: 2018-01-16→ Common Stock (25,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2008-01-17−30,350→ 0 total
Exercise: $2.25Exp: 2008-02-25→ Common Stock (30,350 underlying)
Award
Stock Option (Right to Buy)
2008-01-17+30,350→ 30,350 total
Exercise: $2.25Exp: 2013-02-25→ Common Stock (30,350 underlying)
Award
Stock Option (Right to Buy)
2008-01-17−3,000→ 3,000 total
Exercise: $1.62Exp: 2018-01-16→ Common Stock (3,000 underlying)

Footnotes (4)

[F1]25% of the shares subject to the Stock Option shall vest and become exercisable on the first anniversary of the date of grant. The balance of the shares shall vest and become exercisable in 36 equal monthly installments thereafter.
[F2]Amendment of an outstanding Stock Option in order to extend the termination date of the exercise period for the remaining 30,350 shares subject to the Stock Option from February 26, 2008 to February 26, 2013 resulting in deemed cancellation of the Stock Option and grant of a replacement Stock Option. The Stock Option was originally granted on February 26, 2003 for 40,000 shares and was fully vested and exercisable upon grant.
[F3]Fully vested and exercisable upon grant.
[F4]The shares subject to the Stock Option shall vest and become exercisable in 12 equal monthly installments.

Documents

1 file